Business Description
Sedana Medical AB
ISIN : SE0015988373
Compare
Compare
Traded in other countries / regions
SEDANA.Sweden7D2A.Germany IPO Date
2018-07-20Description
Sedana Medical AB is a Sweden-based medical technology company. It is a pioneer MedTech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. The product range of the group is Sedaconda ACD, Sedaconda, AnaConDa, FlurAbsorb, Gas Monitor, Adapters, and Accessories. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 31.26 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.31 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 24.52 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.4 | |||||
| 3-Year EBITDA Growth Rate | -49.2 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | -27.8 | |||||
| 3-Year Book Growth Rate | 17.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 37.04 | |||||
| Future 3-5Y Total Revenue Growth Rate | 21.84 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 86.61 | |||||
| 9-Day RSI | 79.15 | |||||
| 14-Day RSI | 72.16 | |||||
| 6-1 Month Momentum % | -53.98 | |||||
| 12-1 Month Momentum % | -52.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.91 | |||||
| Quick Ratio | 6.02 | |||||
| Cash Ratio | 5.06 | |||||
| Days Inventory | 298.1 | |||||
| Days Sales Outstanding | 42.63 | |||||
| Days Payable | 55.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.5 | |||||
| Shareholder Yield % | 0.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.6 | |||||
| Operating Margin % | -32.03 | |||||
| Net Margin % | -32.87 | |||||
| FCF Margin % | -113 | |||||
| ROE % | -5.86 | |||||
| ROA % | -5.56 | |||||
| ROIC % | -8.4 | |||||
| ROC (Joel Greenblatt) % | -172.59 | |||||
| ROCE % | -4.9 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.36 | |||||
| PB Ratio | 2.08 | |||||
| Price-to-Tangible-Book | 8.87 | |||||
| EV-to-EBIT | -36.74 | |||||
| EV-to-Forward-EBIT | -65.47 | |||||
| EV-to-EBITDA | -74.67 | |||||
| EV-to-Forward-EBITDA | -441.9 | |||||
| EV-to-Revenue | 10.13 | |||||
| EV-to-Forward-Revenue | 7.93 | |||||
| EV-to-FCF | -8.92 | |||||
| Price-to-Net-Current-Asset-Value | 9.37 | |||||
| Price-to-Net-Cash | 12.97 | |||||
| Earnings Yield (Greenblatt) % | -2.72 | |||||
| FCF Yield % | -9.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sedana Medical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 15.432 | ||
| EPS (TTM) (€) | -0.05 | ||
| Beta | 1.38 | ||
| Volatility % | 83.26 | ||
| 14-Day RSI | 72.16 | ||
| 14-Day ATR (€) | 0.062296 | ||
| 20-Day SMA (€) | 1.3326 | ||
| 12-1 Month Momentum % | -52.39 | ||
| 52-Week Range (€) | 0.878 - 2.39 | ||
| Shares Outstanding (Mil) | 99.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sedana Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sedana Medical AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sedana Medical AB Frequently Asked Questions
What is Sedana Medical AB(FRA:7D2A)'s stock price today?
The current price of FRA:7D2A is €1.69. The 52 week high of FRA:7D2A is €2.39 and 52 week low is €0.88.
When is next earnings date of Sedana Medical AB(FRA:7D2A)?
The next earnings date of Sedana Medical AB(FRA:7D2A) is 2025-02-14 Est..
Does Sedana Medical AB(FRA:7D2A) pay dividends? If so, how much?
Sedana Medical AB(FRA:7D2A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers